View:
Download DOC
Download PDF
Download XLS
Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 25, 2024 5:00 P.M.
Form:
S-1
CIK:
0001868279
Company Name:
ArriVent Biopharma, Inc.
File Number:
333-276397